v3.26.1
Nature of Business - Additional Information (Details)
$ in Millions
6 Months Ended
Jun. 30, 2026
USD ($)
Segment
Product
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Operating segments (in segments) | Segment 1
FDA approved products (in products) | Product 0
Cash, cash equivalents and marketable securities | $ $ 320.4